Public Release: 

Running prevents postnatal side effects of epilepsy drugs in mice

Cell Press

The simple act of running may be sufficient to prevent long-term cognitive impairments caused by prenatal exposure to antiepileptic drugs, according to a study published November 19th in Stem Cell Reports, the journal of the International Society for Stem Cell Research. The findings revealed that prenatal exposure to a commonly used antiepileptic drug called valproic acid (VPA) inhibited the birth of new neurons in the brains of adult mice and impaired their performance on learning and memory tasks. Remarkably, these postnatal side effects were largely prevented when the mice were given access to a running wheel at a young age.

"Currently, the children of epileptic women who take VPA during pregnancy suffer cognitive deficiencies without any available methods for prevention or treatment," says senior study author Kinichi Nakashima of Kyushu University. "If the findings are supported by future clinical trials in humans, then voluntary exercise could be considered as a way to improve the intellectual functioning of these children."

Epilepsy is one of the most common neurological disorders globally, affecting an estimated 50 million people worldwide. Approximately 30% of sufferers are women of childbearing age, and antiepileptic drugs such as VPA are commonly given during pregnancy. But recent studies in humans have suggested that prenatal exposure to these drugs could lower IQ scores and cause wide-ranging cognitive deficits in childhood. Because the underlying molecular mechanisms are unclear, there are currently no effective treatments for affected children of epileptic mothers who took antiepileptic drugs during pregnancy.

In the new study, Nakashima and his team found that prenatal exposure to VPA enhanced the birth of new neurons in the brains of embryos, rapidly depleting the pool of neural precursor cells. As adults, these mice showed a decrease in the birth of new neurons in a brain region called the hippocampus, as well as deficits in several learning and memory tasks. But voluntary exercise on a running wheel for two months at a young age increased neurogenesis in the hippocampus and largely prevented learning and memory deficits.

However, many questions need to be answered before the findings can be translated to humans. For example, the study was conducted on non-epileptic pregnant mice thatmay respond differently to VPA than epileptic patients. Moreover, it is still not clear exactly how voluntary exercise improves cognitive performance following prenatal VPA exposure. Addressing these issues will be important for developing appropriate therapies for humans.

With this goal in mind, Nakashima and his collaborators will next examine whether voluntary exercise improves cognitive functioning by restoring the normal balance of excitatory and inhibitory signals in the hippocampus. They also plan to examine the potential role of other brain regions involved learning and memory. "Any information gathered from these follow-up experiments will improve our understanding of the pathology and open up new avenues for further exploration of better treatment methods."


This research was supported in part by the NAIST Global COE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); a Grant-in-Aid for Scientific Research on Innovative Area: Neural Diversity and Neocortical Organization from MEXT; Health Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan; Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Corporation; and Research Fellowships for Young Scientists from the Japan Society for the Promotion of Science.

Stem Cell Reports, Juliandi and Tanemura et al.: "Reduced Adult Hippocampal Neurogenesis and Cognitive Impairments following Prenatal Treatment of the Antiepileptic Drug Valproic Acid"

Stem Cell Reports, published by Cell Press for the International Society for Stem Cell Research (@ISSCR), is a monthly open-access forum communicating basic discoveries in stem cell research, in addition to translational and clinical studies. The journal focuses on shorter, single-point manuscripts that report original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians. For more information, please visit To receive media alerts for this or other Cell Press journals, please contact

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.